(PIRS) Pieris Pharmaceuticals Renko charts technical analysis
(PIRS) Pieris Pharmaceuticals Renko charts technical analysis Renko analysis of Pieris Pharmaceuticals | Buy/Sell Pieris Pharmaceuticals
Pieris Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Pieris Pharmaceuticals is 20934
| Date | Closing Price | Open | High | Low | Volume |
| 13 Fri Dec 2024 | 13.60 | 15.01 | 15.01 | 13.26 | 0.052 Mn |
| 12 Thu Dec 2024 | 16.16 | 16.34 | 16.58 | 16.11 | 0.005 Mn |
| 11 Wed Dec 2024 | 16.60 | 16.85 | 16.93 | 16.24 | 0.012 Mn |
| 10 Tue Dec 2024 | 17.00 | 16.41 | 17.36 | 16.30 | 0.111 Mn |
| 09 Mon Dec 2024 | 16.52 | 16.24 | 16.60 | 16.24 | 0.005 Mn |
| 26 Tue Nov 2024 | 17.07 | 16.99 | 17.07 | 16.84 | 0.006 Mn |
| 26 Tue Nov 2024 | 17.07 | 16.99 | 17.07 | 16.84 | 0.006 Mn |
| 25 Mon Nov 2024 | 16.84 | 15.85 | 17.00 | 15.85 | 0.03 Mn |
| 22 Fri Nov 2024 | 16.77 | 15.89 | 16.97 | 15.89 | 0.016 Mn |
| 21 Thu Nov 2024 | 15.93 | 15.39 | 16.01 | 15.39 | 0.011 Mn |
Indicators analysis of Pieris Pharmaceuticals (PIRS)
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Pieris Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pieris Pharmaceuticals in short term and the sell signal is strong.
Pieris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Pieris Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Pieris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.18 and Pieris Pharmaceuticals (PIRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pieris Pharmaceuticals (PIRS) stock. Volume based technical analysis of Pieris Pharmaceuticals (PIRS) stock is negative.
Pieris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Pieris Pharmaceuticals ( (PIRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Pieris Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pieris Pharmaceuticals in short term and the sell signal is strong.
Pieris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Pieris Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Pieris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.18 and Pieris Pharmaceuticals (PIRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pieris Pharmaceuticals (PIRS) stock. Volume based technical analysis of Pieris Pharmaceuticals (PIRS) stock is negative.
Pieris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.